Credit: Pixabay

People with narcolepsy needed

Kelowna - Okanagan Clinical Trials is conducting a new study

Can’t sleep? One medical research centre in Kelowna is asking those with narcolepsy to participate in a study.

Okanagan Clinical Trials is currently conducting a study to determine the effectiveness of an investigational medication in treating excessive daytime sleepiness in type 1 and 2 narcolepsy.

“Narcolepsy often takes years to recognize and is often misdiagnosed. It is estimated that only 25 per cent of people who have narcolepsy have been diagnosed and are receiving treatment. Narcolepsy affects an estimated three million people worldwide,” said Dr. Paul Latimer, psychiatrist and principal investigator for Okanagan Clinical Trials.

Narcolepsy can be difficult to diagnose because some of its symptoms, such as fatigue, are common to many conditions, according to a Clinical Trials release.

Narcolepsy is diagnosed through a sleep study, a set of medical tests including an overnight polysomnogram which will be performed at the Kelowna Sleep Clinic. A sleep study is necessary to rule out sleep apnea and other possible sleep disorders that could contribute to excessive daytime sleepiness.

A total of 264 patients will participate in this clinical study worldwide. Okanagan Clinical Trials was selected to participate because of its proven track record in conducting clinical trials since 1992. Eligible volunteers for this study will be men and women above the age of 16 who have documented evidence of a diagnosis of narcolepsy. Volunteers meeting this and other criteria will be asked to undergo a screening visit to determine eligibility.

The duration of the study is approximately 17 weeks and participants are seen nine times at Okanagan Clinical Trials and two times at the Okanagan Sleep Clinic.

Patients will receive study medication and must be willing to comply with the requirement to remain in bed for a minimum of six hours after taking the study drug. All office visits and medical evaluations related to this study will be provided to participants at no charge. Participants may also be reimbursed for their travel and other incidental expenses.

Okanagan Clinical Trials can be reached at 250-862-8141 for more information.

Just Posted

UPDATED: Man dies after struck by vehicle

A man died after being hit by a vehicle in West Kelowna

Your weekend story highlights

Each weekend, we choose top stories from the week for you to enjoy

Chinese pioneers honoured

A sign was unveiled in City Park Saturday to honour the Chinese contributions to Kelowna

Search at Silver Creek property enters third day

A portion of the property has been cordoned off with black landscaping fabric

Corn maze owner deters vandals with cameras

The Kelowna Corn Maze now cameras installed on the property

VIDEO: Sears liquidation sales continue across B.C.

Sales are expected to continue into the New Year

Vehicle leaves scene after striking lamp post

After hitting a lamp post on Springfield Road, a vehicle has left the scene

New B.C. acute care centre opens for young patients, expectant mothers

Facility aims to make B.C. Children’s Hospital visits more comfortable

Search ramps up for B.C. woman after dog, car found near Ashcroft

Jenny Lynn Larocque’s vehicle and dog were found in Venables Valley, but there is no sign of her

Raven story shines light at Children’s Showcase

Season opener of the Children’s Showcase in Penticton

Okanagan Taste: Snacks and what to pair with them

Your guide to for the go-to snacks and beverage pairings for sports season

Police officer hit by car, stabbed in Edmonton attack back on job

Const. Mike Chernyk, 48, returned to work Thursday

UBC medical students learn to care for Indigenous people

Students in health-related studies to take course, workshop to help better serve Aboriginal people

Tolko pledges to support women in leadership roles

Vernon - Brad Thorlakson, CEO of Tolko Industries, added his name to the Minerva Diversity Pledge

Most Read